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Hydroxymethylcytosine has been shown to be involved in DNA demethylation and gene expression.
Although methods to determine the position of hydroxymethylcytosine at single-base resolution
have been reported, thesemethods involve some difficulties. Here, we report a simplemethod to ana-
lyze hydroxymethylcytosine in the CpG sequence utilizing themaintenance DNAmethylation activity
of DNMT1, which selectively methylates hemi-methylated but not hemi-hydroxymethylated CpG
sequences. The method enables monitoring of the dynamics of the hydroxymethylation state of a
specific genome site.
 2015 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In mammals, cytosine in the CpG sequence is often methylated
by DNA methyltransferase (Dnmt) [1–3]. Methylated cytosine
(5mC) plays crucial roles in gene silencing, genomic imprinting,
X-chromosome inactivation and the stability of genomic DNA
[4,5]. Aberrant DNA methylation causes embryonic lethality and
cancer [6,7]. Recently, 5-hydoxymethylcytosine (5hmC) was dis-
covered to be a new modification of cytosine [8,9], being an inter-
mediate of the demethylation process, and thus is implicated in the
pluripotency of stem cells, development, and disease [10,11].
5hmC, which is relatively abundant in brain and embryonic stem
(ES) cells [12,13], is produced through hydroxylation of 5mC by
oxygenase, ten-eleven translocation (Tet), Tet1, Tet2, and Tet3
[14–16]. 5hmC plays a role in gene expression regulation during
cell differentiation and maintenance of pluripotency, and thus reg-
ulation of the hydroxylation of 5mC to 5hmC is essential.The macroscopic distribution of 5hmC in nuclei has been exam-
ined by using a specific antibody against 5hmC [17], 5hmC-specific
restriction endonucleases [18,19], or labeling of 5hmC with biotin
by the click reaction [20]. For detailed analysis of 5hmC, a method
to determine the position of 5hmC at the single-base level is nec-
essary. Bisulfite (BS) sequencing, which now is a standard method
to analyze 5mC, identifies 5hmC as 5mC [21]. To determine 5hmC
at single-base resolution, five techniques, oxBS-seq [22], Tet-
assisted BS sequencing (TAB-seq) [23], oxidation of 5hmC with a
peroxotungsten catalyst [24], Pvu-seal-seq [25], and glucosylation
coupled with restriction-enzyme digestion [26] have been
reported. However, each method has advantages and disadvan-
tages. Perruthenate used in oxBS-seq method tends to damage
DNA and the oxidized product of 5-formylcytosine is difficult to
deaminate, and TAB-seq requires a highly active Tet enzyme [20].
The other three methods have limitations in the sequences they
can analyze.
In the present study, we have developed a novel method to
determine 5hmC in the CpG sequence utilizing DNA methyltrans-
ferase 1 (DNMT1), which scarcely methylates hemi-
hydroxymethylated DNA [27]. We named this method DNMT1
methylation activity-assisted BS sequencing (DMAB-seq), which
involves a different tool from those previously reported. This
method can be used to easily monitor the 5hmC modification sta-
tus at a specific genomic locus and is a useful technique to examine
the dynamic change of 5hmC during a biologically important
process.
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2.1. Preparation of recombinant DNMT1
Full-length DNMT1 was prepared as described elsewhere [28].
Briefly, His- and GSH-tagged DNMT1 cDNA in baculovirus was
expressed in insect cells Sf9 and purified. The protein concentra-
tion was determined from the absorbance at 280 nm using the
molar extinction coefficient.
2.2. Analysis of 5hmC using synthetic DNA
Annealed DNA (Supplemental Table S1) was methylated with
DNMT1 in buffer A comprising 5 mM EDTA, 12 mM NaCl, 2.7 M
glycerol, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM
dithiothreitol (DTT), 20 mM Tris–HCl (pH 7.4), and the indicated
concentrations of KCl in the presence of 1 mM S-adenosyl-L-
methionine (SAM). BS treatment was performed with Epitect bisul-
fite kit (Qiagen) according to the manufacturer’s instructions with
an extra one hour’s BS treatment at 60 C. After the BS treatment,
DNA was amplified with EpiTaq (Takara) and specific primers (Sup-
plemental Table S1), and then purified with MinElute PCR purifica-
tion kit (Qiagen). The purified DNA was subcloned into
pBlueScriptII, and then its sequence was determined by the
dideoxy method.
2.3. In silico analysis of CpG dinucleotide density in the mouse and
human genomes
The distances between CpGs and the numbers of CpG repeti-
tions were calculated using an in-house perl script, which is avail-
able on request. Genome assembly versions hg19 and mm10 for
man and mouse, respectively, were used for the whole-genome
analysis. A list of CpG islands for man and mouse was downloaded
from the UCSC genome browser.
2.4. Cell culture
E14Tg2a mouse ES cells were cultured on gelatin-coated dishes
in the presence of 1000 U/ml of LIF (in house) containing 20% (v/v)
Knockout Serum Replacement (including vitamin C) (Invitrogen) in
DMEM supplemented with non-essential amino acids, sodium
pyruvate, 2-mercaptoethanol, penicillin/streptomycin, and two
kinase inhibitors, 2i (3 lM CHIR99021 and 1 lM PD0325901). As
for the vitamin C and 2i minus conditions, 20% fetal bovine serum
(FBS) was used instead of KSR. After switching the culture medium,
ES cells were maintained for 10 days before DMAB-seq.
2.5. Preparation of spike DNA
The Morc1 upstream region with an inserted AT sequence (Sup-
plemental Fig. S1) was amplified by PCR with specific primers
(Supplemental Table S1) using LA Taq polymerase (Takara). Fully
methylated, hydroxymethylated, or unmodified DNA was ampli-
fied in the presence of 5-methyl-dCTP (ZymoResearch), 5-
hydroxymethyl-dCTP (ZymoResearch), or dCTP, respectively, and
dATP, dTTP, and dGTP. The amplified DNA was purified with
AMPure XP beads (Beckman Coulter). The concentrations of the
fragments were determined from the absorbance at 260 nm.
2.6. Application of DMAB-seq to genomic DNA
Genomic DNA (1 lg), prepared from E14Tg2a mouse ES cells
with Wizard DNA purification kit (Promega), was digested with
EcoRI. To the digested DNA, 300 fg of spike DNA and 10 pmol ofbiotin-labeled Morc1 primer (Supplemental Table S1 and Fig. S1)
were mixed in 6.6 ll of annealing buffer comprising 50 mM NaCl,
1 mM EDTA, and 10 mM Tris–HCl (pH 8.0). The mixture was incu-
bated at 95 C and then gradually cooled down to 15 C, and then
the primer was extended with 5 units of T4 polymerase (Toyobo)
at 37 C for 10 min. Excess biotin-labeled primer was removed
with AMPure XP beads. The purified genomic DNA was methylated
with 0.5–3 lg of recombinant DNMT1 at 37 C for 1 h in 25 ll of
buffer A supplemented with 108 mM KCl, 12 mM NaCl and 1 mM
SAM. After the methylation, the reaction mixture was digested
with Proteinase K, and then BS-treated as described above. The
biotin-labeled DNA fragment was purified with Dynabeads M-
280 Streptavidin beads (Invitrogen). The beads were suspended
with 20 ll of 10 mM Tris–HCl (pH 8.0), and then one-fifth of the
mixture was PCR amplified with the primer set (Supplemental
Table S1). The amplified DNA was subcloned into pBlueScriptII
and then the sequence was determined as described above.
3. Results
Two powerful techniques, TAB-seq and oxBS-seq, to analyze
5hmC at single-base resolution have been reported [22,23]. In
the present study, we have developed an alternative method utiliz-
ing DNMT1. DNMT1 is reported to preferentially methylate the
hemi-methylated state of CpG, but to scarcely methylate its
hemi-hydroxymethylated state [27]. This unique methylation
property of DNMT1 was utilized for the analysis of 5hmC in the
CpG sequence. The experimental outline is shown in Fig. 1A. Firstly,
the target sequence to be analyzed is primer extended with a
specific primer to produce hemi-methylated and hemi-
hydroxymethylated states (Step 1). Secondly, the synthesized
DNA is treated with DNMT1 to produce fully-methylated DNA
except for unmodified and hemi-hydroxymethylated sites (Step
2). As DNMT1 scarcely methylates hemi-hydroxymethylated DNA
[27], not the hydroxymethylated but only the methylated CpGs
in the parent strand are copied to the newly synthesized strand.
Finally, the DNA is BS-treated to determine the methylation sites
(Step3). Comparison of the methylation states of parent and
DNMT1-treated DNA provides the 5hmC sites, which are expected
to be converted to T (U).
3.1. Optimization of DNMT1 reaction conditions
To optimize the conditions of the methylation reaction of
DNMT1, we utilized 100bp_6CpG (Supplemental Table S1) com-
prising two unmodified (C1 and C2), two hemi-methylated (M1
and M2), and two hemi-hydroxymethylated (H1 and H2) CpGs
(Fig. 1B). Under 12 mM NaCl and 108 mM KCl conditions, 88%
and 96% of hemi-methylated site of M1 and M2, respectively, of
DNA (62 ng) were methylated with DNMT1 (0.92 lg). Under these
conditions, about 10%, respectively, of unmodified C1 and C2, and
23% and 7% of the hemi-hydroxymethylated sites H1 and H2,
respectively, were methylated (Fig. 1C and Supplemental
Fig. S2A). When the amount of DNMT1 in the reaction mixture
was increased from 0.92 to 3 lg, 88% and 100% of hemi-
methylated sites M1 and M2, respectively, were determined to
be methylated, while 41% and 31% of hemi-hydroxymethylated
sites H1 and H2, respectively, were determined to be methylated
(Fig. 1C). The ratio of DNMT1 to DNA is the crucial factor for the
substrate specificity of DNMT1.
Since DNA methyltransferases are sensitive to salt concentra-
tions, and the DNA methylation activity is inhibited at above phys-
iological salt concentrations [29], we next examined the salt
concentration-dependent DNA methylation activity of DNMT1
towards DNA containing hemi-methylated, unmodified, and
Fig. 1. Optimization of DNA methylation conditions with DNMT1 using model DNA containing unmodified, hemi-methylated, and hemi-hydroxymethylated CpG. (A) Outline
of DMAB-seq. Unmodified (C), methylated (5mC), and hydroxymethylated (5hmC) CpG are shown as open, closed, and gray circles, respectively. (B) DNA sequence of 60 bp of
the 100bp_6CpG used for the model experiment (Supplemental Table S1), and the analytical processes are shown. Two each of unmodified (C1 and C2), methylated (M1 and
M2), and hydroxymethylated CpGs (H1 and H2) are indicated. (C) DNMT1 dose-dependent methylation of the 100bp_6CpG. The DNA was methylated with the indicated
ratios of DNMT1, and then the DNA methylation was determined by BS sequencing. The numbers determined to be CpG over numbers of CpG examined {CpG/(CpG + CpT)} at
each CpG site are shown. Raw data are shown in Supplemental Fig. S2A. (D) Salt concentration-dependency of DNA methylation of the 100bp_6CpG by DNMT1. DNMT1
methylation reactions were performed with the indicated KCl concentrations and 12 mM NaCl, using 0.92 lg of DNMT1 and 62 ng of oligonucleotide. Raw data are shown in
Supplemental Fig. S2B. (E) Site-specific methylation analysis of the 100bp_6CpG under the optimal conditions. Three independent experiments were performed and the
averages ± S. D. are shown in the left panel. Raw data for the methylated (closed circles) and un-methylated (open circles) sites with or without DNMT1 are shown in the right
panel.
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from 0 to 200 mM with the constant concentration of 12 mM NaCl
derived from the DNMT1 preparation (Fig. 1D and Supplemental
Fig. S2B). With 38 mM KCl, 80% and 53% of the
hemi-hydroxymethylated sites of H1 and H2, respectively, were
methylated. With 108 mM KCl, 23% and 7% of the hemi-hydroxymethylated sites of H1 and H2, respectively, and about
10% of the unmodified C1 and C2 sites were methylated. Under
identical salt conditions, 87% and 100% of M1 and M2, respectively,
were methylated. With the higher concentration of KCl (188 mM),
more than 85% of all the CpG sites remained un-methylated. From
these findings, we set the conditions for the methylation reaction
744 S. Takahashi et al. / FEBS Open Bio 5 (2015) 741–747as 12 mM NaCl and 108 mM KCl at 37 C with 15 (w/w) DNMT1/
DNA for synthesized DNA.
Under the above conditions, three independent DNA methyla-
tion reactions were performed (Fig. 1E). The two hemi-
methylated CpG sites were 82 ± 10 (M1) and 86 ± 1% (M2) methy-
lated, the two hemi-hydroxymethylated CpG sites were 13 ± 7 (H1)
and 15 ± 1% (H2) methylated, and the un-methylated CpG sites
were 14 ± 10 (C1) and 4 ± 4% (C2) methylated. This indicates that
the method can discriminate hemi-hydroxymethylated CpG from
hemi-methylated CpG with an eightfold preference.
3.2. Effect of density of DNA methylation or hydroxymethylation on
DNMT1 methylation activity
As dense CpG methylation affects the de novo methylation
activity of mouse Dnmt1 [30], we next examined the effect of
the CpG density on DNMT1 methylation. We designed another
synthetic DNA substrate, 100bp_7CpG, with a higher CpG density
(Fig. 2A, upper panel, and Supplemental Table S1). The DNA
methylation activity of DNMT1 towards hemi-
hydroxymethylated sites H1 and H2 was significantly lower than
towards those hemi-methylated sites M1 and M3. The hemi-
methylated site, M2, however, was not efficiently methylated
compared to the neighboring two hemi-methylated sites, M1
and M3 (Fig. 2A, lower panel). To further evaluate the effect of
the local density of methylated and hydroxymethylated CpG on
the activity of DNMT1, we designed the synthesized DNA
70bp_10CpG (Fig. 2B, upper panel, and Supplemental Table S1).
DNMT1 efficiently methylated the hemi-hydroxymethylated sites
H1 and H3, and H4, the one next to hemi-methylated M2 (Fig. 2B,Fig. 2. Effects of the densities of methylated and hydroxymethylated CpG on DNMT1
(46 ng) (B), was methylated with DNMT1 (0.92 lg) under the optimized conditions and
hemi-methylated (M1–M3), and two hemi-hydroxymethylated (H1, H2) CpGs, while 70b
hydroxymethylated (H1–H4) sites (upper panels and Supplemental Table S1). The res
averages ± S. D. are shown in the bottom panels.lower panel). DNA methylation of the hemi-methylated sites, M3-
5, was not affected by the density. These results indicate that the
maintenance DNA methylation activity of DNMT1 is strongly
affected by neighboring CpG methylation and hydroxymethyla-
tion, and thus DMAB-seq may not be applicable to a DNA
sequence with a high CpG density and with high levels of methy-
lation or hydroxymethylation. However, when the distance
between two CpG sequences was more than 5 bp, DNMT1 prop-
erly recognized the modification status (Figs. 1 and 2).
3.3. Application of DMAB-seq to genomic DNA
Since DNMT1 methylation activity was affected by the 5mC and
5hmC densities, we analyzed the CpG distribution in both mouse
and human genomes in silico. For the distances between the two
CpGs that are less than 150 bp apart from each other, the medians
are 27 and 33 bp, and the averages are 40 and 46 bp for human and
mouse genomes, respectively (Supplemental Fig. S3A). Further-
more, the population of distances of more than 5 bp between
two CpGs is 87% and 89% in human and mouse genomes,
respectively.
Analysis of the consecutive CpG sequences in human and mouse
genomes indicated that tandem CpG is observed with an about
one-tenth probability compared to an orphan CpG (Supplemental
Fig. S3B). The population of orphan CpGs in both human and mouse
whole genomes is 98% (Supplemental Fig. S3B). Even in CpG
islands, there is a one-tenth probability of a tandem CpG compared
to an isolated single CpG (Supplemental Fig. S3C).
Therefore, DMAB-seq can be applied to most human and mouse
genome regions.methylation activity. A synthesized DNA, 100bp_7CpG (62 ng) (A) or 70bp_10CpG
then analyzed as in Fig. 1E. 100bp_7CpG contains two unmodified (C1, C2), three
p_10CpG contains one unmodified, five hemi-methylated (M1–M5), and four hemi-
ults of three independent experiments are shown in the middle panels, and the
Fig. 3. Culture condition-dependent changes of DNA modifications at specific CpG sites inMorc1. (A) Illustration of the position of the AT spike. The four CpG sites inMorc1 50
upstream region (vertical lines), the gene body (gray box), and the DNA sequences around the AT spike are shown. (B) DNA modifications in ES cells cultured with KSR in the
presence of 2i were determined. The methylation state of the CpG1 site in the Morc1 gene was determined by BS-seq and DMAB-seq, and representative results for
experiment 1 on the CpG1 are shown (left panel). The CpG sites determined to be T and C are shown as open and closed circles, respectively. The results of more than three
independent experiments are shown as a bar graph with averages ± S. D. (n = 3 or 9) (right panel). The background (BG) of DMAB-seq (dotted line) was estimated to be
approximately 8% (average of two backgrounds, 5.6% and 9.3%, for 5hmC and C in spike DNA, respectively). (C) DNA modifications in ES cells cultured in the presence of FBS
and absence of 2i were determined and are shown. The background (BG) of DMAB-seq (dotted line) was estimated to be approximately 5% (average of two backgrounds, 2%
and 8%, for 5hmC and C in spike DNA, respectively). All the raw data for the calculation are shown in Supplemental Fig. S4. (D) The amounts of methylated,
hydroxymethylated, and unmodified CpG at the CG1 site ofMorc1 gene of the genome prepared from cells cultured in the presence (KSR) or absence (FBS) of vitamin C and 2i.
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ES cells
In the genome of mouse ES cells, cytosine bases at chr16:
48431084 (mm9) located upstream of Morc1 gene are reported
to be highly hydroxymethylated [23]. We used this region for eval-
uation of DMAB-seq. Firstly, we performed BS sequencing of the
four CpG sequences, CpG1-4, of the upstream region ofMorc1 gene
(Supplemental Fig. S1). We found 44 ± 5% (three independent
experiments; n = 3) and less than 5% methylation or hydrox-
ymethylation at CpG1 and CpG2-4, respectively (Supplemental
Fig. S4A). This result is consistent with the previous report that
methylation or hydroxymethylation is found at CpG1 by BS
sequencing [31].
To monitor the methylation by DNMT1, unmodified, full-
methylated, or full-hydroxymethylated spike DNA with an ATsequence was mixed with genomic DNA as internal standards
(Fig. 3A). Genomic DNA was mixed with one of the three spike
DNAs, and primer extended with the biotinylated primer, and then
treated with DNMT1. The DNMT1-methylated CpG of the Morc1
upstream region was determined. The methylated, hydroxymethy-
lated, and unmodified spike DNA were determined to be 94 ± 3,
6 ± 6, and 9 ± 2% methylated, respectively (Fig. 3B). The CpG1 of
the parent genomic DNA by DMAB-seq showed apparently
16 ± 3% methylation, while BS-seq showed 44 ± 5% methylation
(Fig. 3B). By subtracting the average of methylation of hemi-
hydroxymethylated and unmodified spike DNA, that is, 8% of the
apparent genome methylation levels obtained by DMAB-seq or
BS-seq, CpG1 was estimated to be 8% methylated, 36% hydrox-
ymethylated, and 56% un-methylated (Fig. 3C, and Supplemental
Fig. S4B). When DMAB-seq was performed without DNMT1 treat-
ment, almost all the CpGs in the spike DNA were determined to
746 S. Takahashi et al. / FEBS Open Bio 5 (2015) 741–747be un-methylated (Supplemental Fig. S5). Taken together, the
results indicate that DMAB-seq can be applied to determine
5hmC at CpG sites.
It was reported that addition of vitamin C to the culture med-
ium increases the global 5hmC level [32], and two kinase inhibitors
(CHIR99021 and PD0325901; 2i) decrease the global 5mC level
[33]. The above analyses were performed in the presence of vita-
min C contained in KSR and 2i. We then analyzed the DNA modifi-
cation state at the CpG1 site of Morc1 gene in the absence of both
vitamin C and 2i by DMAB-seq (Fig. 3C). By calculating the modifi-
cation level as in Fig. 3B, 5mC, 5hmC, and unmodified cytosine at
the CpG1 site in the absence of vitamin C and 2i were estimated
to be 57, 26 and 17%, respectively (Figs. 3C, and Supplemental
Fig. S4C and D). As shown in Fig. 3C, CpG1 in ES cells cultured in
the presence of KSR and 2i showed hypomethylation compared
to those cultured in the absence of vitamin C and 2i in FBS. In addi-
tion, by changing the medium including KSR and 2i to the one with
FBS, the level of 5mC significantly increased while that of 5hmC
moderately decreased at the CpG1 site (Fig. 3D). These results
show that DMAB-seq is a valuable tool to analyze the changes of
the 5hmC and 5mC levels at the CpG sequence in a specific geno-
mic region, and may contribute in understanding of the biological
function of dynamic changes of 5hmC.4. Discussion
In the present study, we have developed a novel method to ana-
lyze the position of 5hmC in the CpG sequence by utilizing the
unique activity of DNMT1, which selectively methylates hemi-
methylated but not hemi-hydroxymethylated CpG sites. Compared
with conventional BS treatment, this method involves only two
extra steps, primer extension and methylation with DNMT1.
The enzymatic property of recombinant DNMT1, which pos-
sesses de novo-type DNA methylation [30], indicates that an excess
amount of DNMT1 may over-introduce de novo CpG methylation in
addition to maintenance methylation. Under the optimized condi-
tions, however, we did not detect significant de novo methylation
activity using synthesized DNA (Fig. 1E) and spike DNA
(Fig. 3B and C). In addition, theoretically, as the parent CpG methy-
lation status is used as a standard, the bias due to de novo methy-
lation activity may be excluded. Another crucial point of the
method is the densities of 5mC and 5hmC in genome, which affect
the selective DNA methylation activity of DNMT1 (Fig. 2). In the
human and mouse genomes, however, about 90% of the CpG sites
are separated not to be affected by the density (Supplemental
Fig. S3). More importantly, regulatory elements in CpG-poor
sequence contexts undergo extensive and dynamic methylation
and demethylation [34].
Methylation on non-CpG sites does occur in the genome, even if
it is at a low level, and these 5hmC sites may suffer from hydrox-
ylation. DMAB-seq cannot analyze these 5hmC sites as DNMT1 is
specific for CpG methylation. However, non-CpG methylation is
rare and thus so is 5hmC at non-CpG sites. Adult brain is reported
to contain a high level of non-CpG methylation, about 18.9% of
total 5mC, and non-CpG 5hmC is only 2.5% of the total 5hmC level
[35]. Thus, failing to measure 5hmC at non-CpG sites may not be
significant in most cases.
It was reported that DNA methyltransferases possess dehydrox-
ymethylation activity in vitro [36,37]. Because of this there might
be an argument that DNMT1 used in the present study catalyzed
dehydroxymethylation during copying of methylation state. The
dehydroxymethylation activities were detected in the absence of
cofactor SAM in both the reports. Since the dehydroxymethylation
activity is the reverse reaction of methylation, it is reasonable to
assume that dehydroxymethylation activity should be detectedonly in the absence of methyl-group donor SAM. In DMAB-seq,
however, an excess of SAM was used for the methylation reaction
by DNMT1. Therefore, it seems unlikely that dehydroxymethyla-
tion occurred during the methylation reaction.
As an example, we have chosen the CpG1 site of the 50 upstream
region of Morc1 gene, which is reported to be 44% hydroxymethy-
lated [23]. By DMAB-seq, we successfully determined the CpG1 site
to be 35% hydroxymethylated. However, one disadvantage of
DMAB-seq is that when the basal 5mC content is high, the accuracy
of 5hmC determination is reduced. Similar to DMAB-seq, ox-BS-seq
is also affected as to the accuracy of 5hmC quantification by a high
level of 5mC.
During the course of this study, we found that DNMT1 methy-
lated hemi-hydroxymethylated sites when the sites were densely
surrounded by 5mC. It was reported that dense CpG methylation
enhances de novo methylation (30). Both results may suggest that
densely methylated CpG islands are resistant to replication-
dependent demethylation, which may occur at hydroxymethylated
CpG sites [27]. This provides a new concept that densely methy-
lated CpG islands are resistant to Tet-dependent demethylation
due to a unique methylation property of DNMT1.
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